Grattarola R
J Natl Cancer Inst. 1976 Jan;56(1):11-6. doi: 10.1093/jnci/56.1.11.
The urinary testosterone levels of 40 premenopausal and postmenopausal patients with advanced breast carcinoma were assayed before and after ovariectomies. Histologic examination of the ovaries of 25 patients whose hormone levels were above normal revealed interstitial cell hyperplasia. Two months after the operations, the amounts of testosterone excreted by the womaen decreased significantly. We considered this as indirect evidence that the ovaries contributed to androgen synthesis. However, 15 patients had normal hormone excretion values that did not change 2 months postoperatively. Testosterone levels for 6 of the women 5 months after surgery were higher than at the previous testing. We surmised that the increased gonadotropic activity that followed ovariectomy migh have stimulated adrenal androgen secretion. To elucidate this point, we gave injections of 15,000 IU human chorionic gonadotropin (HCG) to breast cancer patients who were free of any recurrence and, 3 or 24 months previously, had undergone prophylactic ovariectomies (5 and 4 patients, respectively). In 5 of these women, the amount of testosterone excreted increased significantly after HGG was administered. We inhibited adrenal androgen secretion in 11 patients, whose presurgical urinary testosterone levels were above normal. After their ovaries were removed, these women received 1.5 mg dexamethaxone (DXM) daily for 30 days at a time, after which the amount of testosterone excreted was evaluated and, if the level was above 5.0 mug/24 hours, therapy was repeated for another 30 days. Of the patients who showed objective remission after ovarietomies, there were 4 (26.3%) of 15 who had normal androgen excretion levels; 8 (57.1%) of 14 had increased amounts and were treated by surgery alone; and 10 (90.9%) of 11 received a combination of ovariectomies and DXM therapy. The duration of regression was the highest in the latter group.
对40例绝经前和绝经后晚期乳腺癌患者在卵巢切除术前及术后测定尿睾酮水平。对25例激素水平高于正常的患者的卵巢进行组织学检查,发现间质细胞增生。术后两个月,这些女性排出的睾酮量显著减少。我们认为这是卵巢参与雄激素合成的间接证据。然而,15例患者的激素排泄值正常,术后2个月未发生变化。6例女性术后5个月的睾酮水平高于前次检测值。我们推测,卵巢切除术后促性腺激素活性增加可能刺激了肾上腺雄激素分泌。为阐明这一点,我们对无任何复发且分别在3个月或24个月前接受过预防性卵巢切除术的乳腺癌患者(分别为5例和4例)注射15000国际单位人绒毛膜促性腺激素(HCG)。在这些女性中,有5例在给予HCG后排出的睾酮量显著增加。我们对11例术前尿睾酮水平高于正常的患者抑制肾上腺雄激素分泌。这些女性在切除卵巢后,每次连续30天每日接受1.5毫克地塞米松(DXM)治疗,之后评估排出的睾酮量,如果水平高于5.0微克/24小时,则再重复治疗30天。在卵巢切除术后出现客观缓解的患者中,15例雄激素排泄水平正常的患者中有4例(26.3%);14例雄激素量增加且仅接受手术治疗的患者中有8例(57.1%);11例接受卵巢切除术和DXM联合治疗的患者中有10例(90.9%)。后一组的缓解持续时间最长。